Skip to search formSkip to main contentSkip to account menu

OT-551

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Nitroxide small molecule agents are in development as preventative or therapeutic pharmaceutical drugs for age-related macular… 
Review
2013
Review
2013
Age-related macular degeneration (ARMD) is the leading cause of irreversible blindness in developed countries. There are… 
Review
2010
Review
2010
PURPOSE To investigate the safety and preliminary efficacy of OT-551, a disubstituted hydroxylamine with antioxidant properties… 
Highly Cited
2007
Highly Cited
2007
PURPOSE OT-551 (1-hydroxy-4-cyclopropanecarbonyloxy-2,2,6,6-tetramethylpiperidine hydrochloride), a TEMPOL-H (OT-674) derivative…